文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

黏膜疫苗:策略与挑战。

Mucosal vaccines: Strategies and challenges.

机构信息

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.

College of Animal Science, Zhejiang University, Hangzhou, China.

出版信息

Immunol Lett. 2020 Jan;217:116-125. doi: 10.1016/j.imlet.2019.10.013. Epub 2019 Oct 25.


DOI:10.1016/j.imlet.2019.10.013
PMID:31669546
Abstract

Mucosal immunization has potential benefits over conventional parenteral immunization, eliciting immune defense in both mucosal and systemic tissue for protecting from pathogen invasion at mucosal surfaces. To provide a first line of protection at these entry ports, mucosal vaccines have been developed and hold a significant promise for reducing the burden of infectious diseases. However, until very recently, only limited mucosal vaccines are available. This review summarizes recent advances in selected aspects regarding mucosal vaccination, including appropriate administration routes, reasonable formulations, antigen-sampling and immune responses of mucosal immunity, and the strategies used to improve mucosal vaccine efficacy. Finally, the challenges of developing successful mucosal vaccines and the potential solutions are discussed.

摘要

黏膜免疫接种相对于传统的注射免疫接种具有潜在的优势,它可以在黏膜和全身组织中引发免疫防御,以防止病原体在黏膜表面的入侵。为了在这些入口处提供第一道防线,已经开发了黏膜疫苗,并为减轻传染病负担提供了巨大的希望。然而,直到最近,只有有限的黏膜疫苗可用。本文综述了黏膜免疫接种的几个方面的最新进展,包括合适的给药途径、合理的制剂、黏膜免疫的抗原采样和免疫反应,以及提高黏膜疫苗效力的策略。最后,讨论了开发成功的黏膜疫苗所面临的挑战和潜在的解决方案。

相似文献

[1]
Mucosal vaccines: Strategies and challenges.

Immunol Lett. 2019-10-25

[2]
Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.

APMIS. 2015-4

[3]
Induction of mucosal immunity through systemic immunization: Phantom or reality?

Hum Vaccin Immunother. 2016-4-2

[4]
B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.

Clin Microbiol Infect. 2012-8-10

[5]
Modern mucosal vaccines, adjuvants and microbicides.

Expert Rev Anti Infect Ther. 2009-2

[6]
Mucosal vaccine design and delivery.

Annu Rev Biomed Eng. 2012-4-18

[7]
Nanocarriers for systemic and mucosal vaccine delivery.

Recent Pat Drug Deliv Formul. 2007

[8]
New insights in mucosal vaccine development.

Vaccine. 2011-11-12

[9]
Stimulation of local antibody production: parenteral or mucosal vaccination?

Trends Immunol. 2002-4

[10]
Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.

J Immunol. 2017-7-1

引用本文的文献

[1]
Nasal and Ocular Immunization with Bacteriophage Virus-like Particle Vaccines Elicits Distinct Systemic and Mucosal Antibody Profiles.

Vaccines (Basel). 2025-8-3

[2]
Mucosal immunity and vaccination strategies: current insights and future perspectives.

Mol Biomed. 2025-8-20

[3]
Automated Glycan Assembly of Lipopolysaccharide Epitopes for Vaccine Design.

J Am Chem Soc. 2025-7-23

[4]
Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants.

J Nanobiotechnology. 2025-7-3

[5]
In silico design and evaluation of a multiepitope vaccine against Bordetella pertussis: structural, immunological, and biological properties.

Genomics Inform. 2025-7-1

[6]
The Functional DPP4 Receptor Is an Indispensable Factor Mediating the Immune Performance of Mucosal Vaccines for Middle East Respiratory Syndrome.

Transbound Emerg Dis. 2025-6-10

[7]
mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection.

Front Cell Infect Microbiol. 2025-5-13

[8]
Protein nanocages: A new frontier in mucosal vaccine delivery and immune activation.

Hum Vaccin Immunother. 2025-12

[9]
Mucosal immunotherapy targeting APC in lung disease.

J Inflamm (Lond). 2025-4-14

[10]
A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model.

Nat Commun. 2025-3-24

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索